Cargando…

Positivity to p-ANCA in patients with status epilepticus

BACKGROUND: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis nam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferlazzo, Edoardo, Gambardella, Antonio, Bellavia, Marina, Gasparini, Sara, Mumoli, Laura, Labate, Angelo, Cianci, Vittoria, Russo, Concetta, Aguglia, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112643/
https://www.ncbi.nlm.nih.gov/pubmed/25033936
http://dx.doi.org/10.1186/1471-2377-14-148
_version_ 1782328198471614464
author Ferlazzo, Edoardo
Gambardella, Antonio
Bellavia, Marina
Gasparini, Sara
Mumoli, Laura
Labate, Angelo
Cianci, Vittoria
Russo, Concetta
Aguglia, Umberto
author_facet Ferlazzo, Edoardo
Gambardella, Antonio
Bellavia, Marina
Gasparini, Sara
Mumoli, Laura
Labate, Angelo
Cianci, Vittoria
Russo, Concetta
Aguglia, Umberto
author_sort Ferlazzo, Edoardo
collection PubMed
description BACKGROUND: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis named ANCA-associated-vasculities (AAV). We herein report 3 patients with SE and positivity to p-ANCA. CASE PRESENTATION: One patient had a catastrophic evolution and died 5 months after disease onset. The other two patients had a good outcome and remained seizure-free at 30 months and 5 years of follow-up respectively. CONCLUSION: This report highlights the importance of considering ANCA dosage in patients with SE of unclear origin.
format Online
Article
Text
id pubmed-4112643
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41126432014-07-29 Positivity to p-ANCA in patients with status epilepticus Ferlazzo, Edoardo Gambardella, Antonio Bellavia, Marina Gasparini, Sara Mumoli, Laura Labate, Angelo Cianci, Vittoria Russo, Concetta Aguglia, Umberto BMC Neurol Case Report BACKGROUND: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are particularly associated with systemic vasculitis named ANCA-associated-vasculities (AAV). We herein report 3 patients with SE and positivity to p-ANCA. CASE PRESENTATION: One patient had a catastrophic evolution and died 5 months after disease onset. The other two patients had a good outcome and remained seizure-free at 30 months and 5 years of follow-up respectively. CONCLUSION: This report highlights the importance of considering ANCA dosage in patients with SE of unclear origin. BioMed Central 2014-07-17 /pmc/articles/PMC4112643/ /pubmed/25033936 http://dx.doi.org/10.1186/1471-2377-14-148 Text en Copyright © 2014 Ferlazzo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Ferlazzo, Edoardo
Gambardella, Antonio
Bellavia, Marina
Gasparini, Sara
Mumoli, Laura
Labate, Angelo
Cianci, Vittoria
Russo, Concetta
Aguglia, Umberto
Positivity to p-ANCA in patients with status epilepticus
title Positivity to p-ANCA in patients with status epilepticus
title_full Positivity to p-ANCA in patients with status epilepticus
title_fullStr Positivity to p-ANCA in patients with status epilepticus
title_full_unstemmed Positivity to p-ANCA in patients with status epilepticus
title_short Positivity to p-ANCA in patients with status epilepticus
title_sort positivity to p-anca in patients with status epilepticus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112643/
https://www.ncbi.nlm.nih.gov/pubmed/25033936
http://dx.doi.org/10.1186/1471-2377-14-148
work_keys_str_mv AT ferlazzoedoardo positivitytopancainpatientswithstatusepilepticus
AT gambardellaantonio positivitytopancainpatientswithstatusepilepticus
AT bellaviamarina positivitytopancainpatientswithstatusepilepticus
AT gasparinisara positivitytopancainpatientswithstatusepilepticus
AT mumolilaura positivitytopancainpatientswithstatusepilepticus
AT labateangelo positivitytopancainpatientswithstatusepilepticus
AT ciancivittoria positivitytopancainpatientswithstatusepilepticus
AT russoconcetta positivitytopancainpatientswithstatusepilepticus
AT agugliaumberto positivitytopancainpatientswithstatusepilepticus